Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events

Seki Tomokazu; Baba Kousuke; Hayashi Tomohiro; Furuta Risako; Hirosawa Hiroaki; Mitsui Taichi; Maesaka Hiroki; Takasawa Syuhei; Miwa Toshiro; Tanaka Keiko; Nakatsuji Yuji

doi:10.2169/internalmedicine.1771-23

Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events

Seki Tomokazu, Baba Kousuke, Hayashi Tomohiro, Furuta Risako, Hirosawa Hiroaki, Mitsui Taichi, Maesaka Hiroki, Takasawa Syuhei, Miwa Toshiro, Tanaka Keiko, Nakatsuji Yuji

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

本文言語	日本
ページ（範囲）	1009-1014
ジャーナル	Internal Medicine
巻	63
号	7
DOI	https://doi.org/10.2169/internalmedicine.1771-23
出版ステータス	出版済み - 2024
外部発表	はい

文献へのアクセス

10.2169/internalmedicine.1771-23

引用スタイル

Tomokazu, S., Kousuke, B., Tomohiro, H., Risako, F., Hiroaki, H., Taichi, M., Hiroki, M., Syuhei, T., Toshiro, M., Keiko, T., & Yuji, N. (2024). Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events. Internal Medicine, 63(7), 1009-1014. https://doi.org/10.2169/internalmedicine.1771-23

@article{80a84449cde84e1487817940379a4f36,

title = "Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events",

author = "Seki Tomokazu and Baba Kousuke and Hayashi Tomohiro and Furuta Risako and Hirosawa Hiroaki and Mitsui Taichi and Maesaka Hiroki and Takasawa Syuhei and Miwa Toshiro and Tanaka Keiko and Nakatsuji Yuji",

year = "2024",

doi = "10.2169/internalmedicine.1771-23",

language = "日本",

volume = "63",

pages = "1009--1014",

journal = "Internal Medicine",

issn = "0918-2918",

number = "7",

}

Tomokazu, S, Kousuke, B, Tomohiro, H, Risako, F, Hiroaki, H, Taichi, M, Hiroki, M, Syuhei, T, Toshiro, M, Keiko, T & Yuji, N 2024, 'Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events', Internal Medicine, vol. 63, no. 7, pp. 1009-1014. https://doi.org/10.2169/internalmedicine.1771-23

TY - JOUR

T1 - Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events

AU - Tomokazu, Seki

AU - Kousuke, Baba

AU - Tomohiro, Hayashi

AU - Risako, Furuta

AU - Hiroaki, Hirosawa

AU - Taichi, Mitsui

AU - Hiroki, Maesaka

AU - Syuhei, Takasawa

AU - Toshiro, Miwa

AU - Keiko, Tanaka

AU - Yuji, Nakatsuji

PY - 2024

Y1 - 2024

U2 - 10.2169/internalmedicine.1771-23

DO - 10.2169/internalmedicine.1771-23

M3 - 学術論文

SN - 0918-2918

VL - 63

SP - 1009

EP - 1014

JO - Internal Medicine

JF - Internal Medicine

IS - 7

ER -